Triple
T15666345
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Clearing-House Mechanism of the Convention on Biological Diversity |
E377196
|
entity |
| Predicate | shortName |
P43
|
FINISHED |
| Object | CBD Clearing-House Mechanism |
E377196
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CBD Clearing-House Mechanism | Statement: [Clearing-House Mechanism of the Convention on Biological Diversity, shortName, CBD Clearing-House Mechanism]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: CBD Clearing-House Mechanism Context triple: [Clearing-House Mechanism of the Convention on Biological Diversity, shortName, CBD Clearing-House Mechanism]
-
A.
Clearing-House Mechanism of the Convention on Biological Diversity
chosen
The Clearing-House Mechanism of the Convention on Biological Diversity is an information-exchange platform designed to promote and facilitate technical and scientific cooperation among parties to support the implementation of the Convention’s objectives.
-
B.
Financial Mechanism of the Convention on Biological Diversity
The Financial Mechanism of the Convention on Biological Diversity is the funding system, primarily operated through institutions like the Global Environment Facility, that supports developing countries in implementing the objectives and commitments of the Convention on Biological Diversity.
-
C.
Conditional Marketing Authorization by European Medicines Agency
Conditional Marketing Authorization by the European Medicines Agency is a fast-track regulatory pathway that allows earlier approval of medicines, such as COVID-19 vaccines, based on less comprehensive data than normally required, provided that the benefits outweigh the risks and additional data will be supplied post-approval.
-
D.
Technical Corrections to the Bayh–Dole Act
Technical Corrections to the Bayh–Dole Act is a legislative measure that refined and clarified the original Bayh–Dole Act’s provisions governing the ownership and commercialization of inventions arising from federally funded research.
-
E.
Clearinghouse
Clearinghouse is a U.S. federal database that tracks commercial drivers’ drug and alcohol program violations to improve roadway safety and compliance.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d85cd2e28481909d4e975bee20872f |
completed | April 10, 2026, 2:13 a.m. |
| NER | Named-entity recognition | batch_69e04f1151548190a14607e762686cb1 |
completed | April 16, 2026, 2:53 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ff67a22888819092ea521bbad7bcb7 |
completed | May 9, 2026, 4:58 p.m. |
Created at: April 10, 2026, 4:16 a.m.